Biopac India (BOM:532330) EBIT: ₹-37.73 Mil (TTM As of Sep. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532330 Biopac India Corp Ltd BOM:532330
4 GF Score
Price ₹1.99
View Full Analysis

What is Biopac India EBIT?

Biopac India BOM:532330 4 EBIT is ₹-37.73 Mil as of Sep. 2020. GuruFocus rates BOM:532330 with a GF Score™ of 4/100.

Biopac India's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2020 was ₹0.81 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2020 was ₹-37.73 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Biopac India's annualized ROC % for the quarter that ended in Sep. 2020 was -3.55%. Biopac India's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was 1.46%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Biopac India's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2020 was -109.91%.

Biopac India  (BOM:532330) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Biopac India's annualized ROC % for the quarter that ended in Sep. 2020 is calculated as:

ROC % (Q: Sep. 2020 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2020 ) + Invested Capital (Q: Sep. 2020 ))/ count )
=-17.768 * ( 1 - 0% )/( (0 + 500.432)/ 1 )
=-17.768/500.432
=-3.55 %

where

Invested Capital(Q: Jun. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Sep. 2020 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=227.937 - 73.331 - ( 0.325 - max(0, 350.683 - 4.857+0.325))
=500.432

Note: The Operating Income data used here is four times the quarterly (Sep. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Biopac India's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2020 is calculated as:

ROC (Joel Greenblatt) %(Q: Sep. 2020 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2020  Q: Sep. 2020
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.252/( ( (0 + max(0, 0)) + (222.403 + max(-109.558, 0)) )/ 1 )
=3.252/( ( 0 + 222.403 )/ 1 )
=3.252/222.403
=1.46 %

where Working Capital is:

Working Capital(Q: Jun. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Sep. 2020 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.042 + 3.967 + 0.36) - (73.331 + 0 + 40.596)
=-109.558

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2020) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Biopac India's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Sep. 2020 )
=-37.73/34.328
=-109.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopac India EBIT Related Terms

Biopac India EBIT Historical Data

* Premium members only.

The historical data trend for Biopac India's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biopac India EBIT Chart

Biopac India Annual Data
Trend Mar10 Mar11 Mar12 Mar13 Mar14 Mar15 Mar16 Mar17 Mar18 Mar19
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.09 45.45 40.76 9.44 -186.98

Biopac India Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Jun20 Sep20
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.76 -26.59 -22.60 -15.95 0.81

BOM:532330 vs BLL, AMCR, IP: EBIT Comparison

For the Packaging & Containers subindustry, Biopac India's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biopac India EV-to-EBIT vs Packaging & Containers Industry

For the Packaging & Containers industry and Consumer Cyclical sector, Biopac India's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Biopac India's EV-to-EBIT falls into.


BOM:532330
4GF Score
Biopac India Corp Ltd BOM:532330
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biopac India EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-37.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹-37.73 Mil mean?
Biopac India (BOM:532330) has a EBIT of ₹-37.73 Mil as of Sep. 2020. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biopac India.
Is Biopac India's EBIT too high?
Biopac India's current EBIT is ₹-37.73 Mil. Overall, Biopac India has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Biopac India's EBIT compare to BLL and AMCR?
Biopac India's EBIT of ₹-37.73 Mil can be compared against companies in the Packaging & Containers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Packaging & Containers company?
A good EBIT depends on the Packaging & Containers industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Biopac India. Biopac India's current EBIT is ₹-37.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biopac India stock overvalued right now?
Biopac India (BOM:532330) has a current EBIT of ₹-37.73 Mil. The current EBIT is ₹-37.73 Mil. Biopac India's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Biopac India (BOM:532330), the current EBIT is ₹-37.73 Mil as of Sep. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biopac India Business Description

Address Off Link Road, 802 , Remi Commercio, 14, Shah Industrial Estate, Andheri (West), Mumbai, MH, IND, 400053
Biopac India Corp Ltd manufactures and sale of food grade polystyrene food service disposable products. Its products include dinnerware comprising plates, soup bowls, serving bowls, serving trays, cups, and readymade lunch trays, flat-type containers/serving bowls, cup-type containers, and box-type and tray containers. The company also provides readymade conveyance and packaging products for poultry, orchard, and seafood export, and ice cream, yogurt, and shrikhand cups, as well as for instant noodle packs, soup containers, and pre-cast molds for PCC tiles.
4GF Score

Get the complete analysis for BOM:532330

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1.99
Price